LivaNova Reports Strong Operational Growth Despite $365.5M Environmental Liability Leading to Net Loss
LIVN has more than doubled off its 52-week low of $32.48 on elevated volume (2.1× avg).
Summary
LivaNova PLC reported a net loss of $242.5 million in 2025 due to a one-time $365.5 million environmental liability, despite achieving strong revenue and operating income growth. The company also significantly reduced its debt and resolved a cybersecurity investigation without penalties.
Key Events · Earnings and Guidance · LIVN
-
Significant Environmental Liability
The company recorded a $365.5 million SNIA environmental liability expense in 2025, following an Italian Supreme Court decision, which was the primary driver of the reported net loss of $242.5 million.
-
Strong Operational Performance
Net revenue increased by 10.7% to $1.39 billion in 2025, with Cardiopulmonary segment revenue up 14.9% and Neuromodulation segment revenue up 7.0%. Operating income rose 54.5% to $199.4 million.
-
Debt Reduction and Improved Liquidity
LivaNova repaid $200 million in long-term debt in 2025 and an additional $97.7 million in January 2026, reducing total debt from $627.6 million to $376.7 million and increasing cash and cash equivalents to $635.6 million.
-
Cybersecurity Investigation Closed
The HHS Office for Civil Rights formally closed its investigation into the November 2023 cybersecurity incident without imposing civil monetary penalties or requiring a corrective action plan.
Analysis · LIVN · Industrial Applications And Services
LivaNova PLC's annual report reveals a significant net loss for 2025, primarily driven by a substantial one-time $365.5 million environmental liability expense related to the SNIA litigation, following a decision by the Italian Supreme Court. This charge overshadowed otherwise strong operational performance, with net revenue increasing by 10.7% and operating income rising by 54.5%. The company also demonstrated robust financial management by repaying $200 million in long-term debt in 2025 and an additional $97.7 million in January 2026, significantly improving its capital structure and liquidity. The positive resolution of a cybersecurity incident investigation by the HHS Office for Civil Rights, with no penalties, further contributes to a mixed outlook. The market's current valuation, with the stock trading near its 52-week high, suggests investors are largely looking past the one-time legal charge and focusing on the company's underlying business strength and future prospects.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LIVN was trading at $70.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.8B. The 52-week trading range was $32.48 to $70.78. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.